secwatch.observer — SEC 8-K summary
======================================

Issuer:     JUPITER NEUROSCIENCES, INC. (JUNS)
CIK:        0001679628
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001493152-25-019783
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jupiter Neurosciences secures up to $20M flexible financing from Yorkville; $4M funded at signing
--------------------------------------------------------------------------------

- Initial $4M pre-paid advance funded via convertible note with $1.50 fixed conversion price and 7% OID.
- Additional $2M pre-paid advance contingent on registration statement and stockholder approval; total $6M pre-paid.
- Up to $14M available under SEPA over 24 months subject to conditions; proceeds to fund Phase 2 Parkinson's trial and Nugevia growth.
- Yorkville receives 131,909 commitment shares and $25K structuring fee; issuance subject to 19.99% Exchange Cap unless stockholder approval obtained.
- Convertible notes bear 8% interest, mature Oct 24, 2026; repayment via cash or advance notices under SEPA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1679628/000149315225019783/0001493152-25-019783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1679628/000149315225019783/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-019783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer